Moldflow Monday Blog

Zoikhem Lab 50 Work -

Learn about 2023 Features and their Improvements in Moldflow!

Did you know that Moldflow Adviser and Moldflow Synergy/Insight 2023 are available?
 
In 2023, we introduced the concept of a Named User model for all Moldflow products.
 
With Adviser 2023, we have made some improvements to the solve times when using a Level 3 Accuracy. This was achieved by making some modifications to how the part meshes behind the scenes.
 
With Synergy/Insight 2023, we have made improvements with Midplane Injection Compression, 3D Fiber Orientation Predictions, 3D Sink Mark predictions, Cool(BEM) solver, Shrinkage Compensation per Cavity, and introduced 3D Grill Elements.
 
What is your favorite 2023 feature?

You can see a simplified model and a full model.

For more news about Moldflow and Fusion 360, follow MFS and Mason Myers on LinkedIn.

Previous Post
How to use the Project Scandium in Moldflow Insight!
Next Post
How to use the Add command in Moldflow Insight?

More interesting posts

Zoikhem Lab 50 Work -

As they worked tirelessly, often going late into the night, their dedication began to bear fruit. They encountered numerous challenges along the way, from off-target effects to efficiency issues. However, through collaboration and relentless pursuit of perfection, they made breakthrough after breakthrough.

The team named their creation "Echo," after the mythological nymph known for repeating the last words spoken to her, symbolizing the technology's ability to 'listen' and adapt to the genetic code in a way that was previously unimaginable. zoikhem lab 50 work

The implications of Echo were profound. It promised a future where genetic diseases could be erased from the human gene pool, passed down through generations. The team at Lab 50 knew they were on the cusp of something revolutionary. As they worked tirelessly, often going late into

The lab fell silent as the scientists headed home, their minds still racing with thoughts of what they had accomplished and what lay ahead. In the quiet moments, as the city outside came alive with the night's activities, the Zoikhem Lab 50 team felt a sense of pride and purpose. They had taken a dream and were turning it into a reality, one that would change the world. The team named their creation "Echo," after the

As news of their work spread, the team received accolades from the scientific community and beyond. However, they remained focused on their goal. Echo was ready to move into clinical trials, a critical step towards making it available to the public.

Check out our training offerings ranging from interpretation
to software skills in Moldflow & Fusion 360

Get to know the Plastic Engineering Group
– our engineering company for injection molding and mechanical simulations

PEG-Logo-2019_weiss

As they worked tirelessly, often going late into the night, their dedication began to bear fruit. They encountered numerous challenges along the way, from off-target effects to efficiency issues. However, through collaboration and relentless pursuit of perfection, they made breakthrough after breakthrough.

The team named their creation "Echo," after the mythological nymph known for repeating the last words spoken to her, symbolizing the technology's ability to 'listen' and adapt to the genetic code in a way that was previously unimaginable.

The implications of Echo were profound. It promised a future where genetic diseases could be erased from the human gene pool, passed down through generations. The team at Lab 50 knew they were on the cusp of something revolutionary.

The lab fell silent as the scientists headed home, their minds still racing with thoughts of what they had accomplished and what lay ahead. In the quiet moments, as the city outside came alive with the night's activities, the Zoikhem Lab 50 team felt a sense of pride and purpose. They had taken a dream and were turning it into a reality, one that would change the world.

As news of their work spread, the team received accolades from the scientific community and beyond. However, they remained focused on their goal. Echo was ready to move into clinical trials, a critical step towards making it available to the public.